⌕
Jazz Pharmaceuticals · JAZZ · Nasdaq
Tenet 47 · Mixed
Compare
$240.71+0.39%At closeTenet 47 · Mixed
$240.71+0.94 (+0.39%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Jazz Pharmaceuticals (JAZZ) Stock

Jazz Pharmaceuticals (JAZZ) closed at $240.71 on Nov 17, 2026; its Tenet Score is 47 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

6 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$240.71
Nov 17, 2026
Market cap
$15.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
75.3×
TTM through Sep 30, 2026 · as of close, Nov 16, 2026
52-week range
139.26 – 266.38
low → high · as of close, Nov 16, 2026
Tenet Score
47/100
Mixed · 340 Healthcare peers

Industry: Drugs

Jazz Pharmaceuticals plc scores 47/100. Mixed. Financial health is the soft spot, trading at 75× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
47/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
41
Quality
61
Health
27
Growth
60

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityCHealthFGrowthCMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
3.7×
Sep 30, 2026 balance sheet
P/S
3.3×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
5%
TTM through Sep 30, 2026
Operating margin
−10.1%
fiscal 2025, before interest and tax
Net margin
4.4%
TTM through Sep 30, 2026
Current ratio
1.82
Sep 30, 2026 balance sheet
Net debt / EBITDA
2.4×
TTM through Sep 30, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product ca…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Jazz Pharmaceuticals in?

Jazz Pharmaceuticals is in the Healthcare sector and the Drugs industry.

What is Jazz Pharmaceuticals' Tenet Score?

Jazz Pharmaceuticals' Tenet Score is 47 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.